Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04900207 · ClinicalTrials.gov registry record
Placental Volume, Flow, and Vascularity Study
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 440
- Enrollment target
NCT04900207: Completed study, sponsored by University of Minnesota.
NCT04900207 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 440 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04900207 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 440 participants
- Enrollment target
Study Summary
The purpose of this preliminary study is to implement an automated and standardized computer-based method that accurately measures placental volume, blood flow, and vascularity. This will be accomplished by using the digital data obtained at the time of a first-trimester 3D image volume. This information will then be used to further investigate whether placental volume, blood flow, and vascularity can be used to predict the risk of preeclampsia in conjunction with maternal history and serum blood markers obtained at the time of their ultrasound.
Primary Outcome
The primary measure for this study will be the positive predictive value of the model for the development of preeclampsia. Outcome is reported as the percent of correct predictions made by the model.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 440 participants |
| Start Date | 2021-03-10 |
| Est. Completion | 2022-06-30 |
What the finished NCT04900207 record still lists
NCT04900207 is an observational study that tracks outcomes without assigning an intervention. The registered 440 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04900207 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04900207 about?
NCT04900207 is a clinical study titled "Placental Volume, Flow, and Vascularity Study". The purpose of this preliminary study is to implement an automated and standardized computer-based method that accurately measures placental volume, blood flow, and vascularity. This will be accomplished by using the digital data obtained at the time of a first-trimester 3D image volume. This inform...
What is the current status of trial NCT04900207?
This trial is currently completed. The enrollment target is 440 participants. The study started on 2021-03-10. Estimated completion is 2022-06-30.
Who is sponsoring clinical trial NCT04900207?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
- NCT05117619 · 440 participants · NA
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
- NCT05602194 · 440 participants · Phase 3
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
- NCT05624879 · 440 participants · NA
Accelerated Resolution Therapy for Early Maladaptive Grief
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI